Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE

OBJECTIVE: Anti-dsDNA antibodies (anti-dsDNA) are a component of all classification schemes in SLE and comprise one of the domains in validated activity indices. Anti-dsDNA is frequently measured commercially by an enzyme immunoassay (EIA) or Crithidia luciliae immunofluorescence test (CLIFT). To ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaminski, Devyn, Saxena, Amit, Izmirly, Peter, Buyon, Jill P, Belmont, H Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Biomarker Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649789/
https://www.ncbi.nlm.nih.gov/pubmed/37963669
http://dx.doi.org/10.1136/lupus-2023-001012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649789/
https://www.ncbi.nlm.nih.gov/pubmed/37963669
http://dx.doi.org/10.1136/lupus-2023-001012

Ejemplares similares